{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:22:56Z","timestamp":1790335376361,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF) of Korea","doi-asserted-by":"crossref","award":["NRF-2012M3A9C4048775"],"award-info":[{"award-number":["NRF-2012M3A9C4048775"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF) of Korea","doi-asserted-by":"crossref","award":["NRF-2017M3A9C8031995"],"award-info":[{"award-number":["NRF-2017M3A9C8031995"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bioorg.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,8,12]],"date-time":"2018-08-12T10:10:53Z","timestamp":1534068653000},"page":"264-269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Ginkgolic acid as a dual-targeting inhibitor for protein tyrosine phosphatases relevant to insulin resistance"],"prefix":"10.1016","volume":"81","author":[{"given":"Sun-Young","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Jeong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang J.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.08.011_b0005","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.ejmech.2017.10.021","article-title":"Dual or multi-targeting inhibitors: The next generation anticancer agents","volume":"143","author":"Raghavendra","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.011_b0010","doi-asserted-by":"crossref","first-page":"31566","DOI":"10.1038\/srep31566","article-title":"Transgenic overexpression of VEGF-C induces weight gain and insulin resistance in mice","volume":"6","author":"Karaman","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2018.08.011_b0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molmet.2014.11.006","article-title":"Blockade of VEGF-C and VEGF-D modulates adipose tissue inflammation and improves metabolic parameters under high-fat diet","volume":"4","author":"Karaman","year":"2015","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.bioorg.2018.08.011_b0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.mce.2012.03.013","article-title":"Tangeretin stimulates glucose uptake via regulation of AMPK signaling pathways in C2C12 myotubes and improves glucose tolerance in high-fat diet-induced obese mice","volume":"358","author":"Kim","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"issue":"9541","key":"10.1016\/j.bioorg.2018.08.011_b0025","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial","volume":"368","author":"Gerstein","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bioorg.2018.08.011_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020340","article-title":"Design, synthesis and in combo antidiabetic bioevaluation of multitarget phenylpropanoic acids","volume":"23","author":"Colin-Lozano","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bioorg.2018.08.011_b0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40268-015-0099-3","article-title":"Imeglimin: a potential new multi-target drug for type 2 diabetes","volume":"15","author":"Vuylsteke","year":"2015","journal-title":"Drugs R D."},{"issue":"4","key":"10.1016\/j.bioorg.2018.08.011_b0040","first-page":"500","article-title":"Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes","volume":"5","author":"Tobin","year":"2002","journal-title":"Curr. Opin. Drug. Discov. Devel."},{"issue":"5","key":"10.1016\/j.bioorg.2018.08.011_b0045","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrd.2017.73","article-title":"Metabolic disease: protein tyrosine phosphatase inhibitor reverses diabetes","volume":"16","author":"Crunkhorn","year":"2017","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"10","key":"10.1016\/j.bioorg.2018.08.011_b0050","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/aps.2014.80","article-title":"Protein tyrosine phosphatases as potential therapeutic targets","volume":"35","author":"He","year":"2014","journal-title":"Acta. Pharmacol. Sin."},{"issue":"24","key":"10.1016\/j.bioorg.2018.08.011_b0055","first-page":"427","article-title":"Association of the PTPN1 gene with type 2 diabetes and insulin resistance","volume":"4","author":"Bowden","year":"2004","journal-title":"Discov. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2018.08.011_b0060","first-page":"367","article-title":"Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling","volume":"3","author":"Cho","year":"2006","journal-title":"CellMetab."},{"issue":"10","key":"10.1016\/j.bioorg.2018.08.011_b0065","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bbadis.2013.05.022","article-title":"Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities","volume":"1832","author":"Hendriks","year":"2013","journal-title":"Biochim. Biophys. Acta."},{"issue":"43","key":"10.1016\/j.bioorg.2018.08.011_b0070","doi-asserted-by":"crossref","first-page":"18116","DOI":"10.1021\/ja308212y","article-title":"A highly selective and potent PTP-MEG2 inhibitor with therapeutic potential for type 2 diabetes","volume":"134","author":"Zhang","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"32","key":"10.1016\/j.bioorg.2018.08.011_b0075","doi-asserted-by":"crossref","first-page":"30187","DOI":"10.1074\/jbc.M302010200","article-title":"Dual specificity mitogen-activated protein (MAP) kinase phosphatase-4 plays a potential role in insulin resistance","volume":"278","author":"Xu","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2018.08.011_b0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbrc.2015.10.004","article-title":"Phosphoprotein phosphatase 1CB (PPP1CB), a novel adipogenic activator, promotes 3T3-L1 adipogenesis","volume":"467","author":"Cho","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2018.08.011_b0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/chem.201002560","article-title":"Development of fluorescent glucose bioprobes and their application on real-time and quantitative monitoring of glucose uptake in living cells","volume":"17","author":"Lee","year":"2011","journal-title":"Chemistry"},{"key":"10.1016\/j.bioorg.2018.08.011_b0090","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.phrs.2017.03.003","article-title":"Identification of sennoside A as a novel inhibitor of the slingshot (SSH) family proteins related to cancer metastasis","volume":"119","author":"Lee","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2018.08.011_b0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1748-1716.2009.01967.x","article-title":"AMPK activators\u2013potential therapeutics for metabolic and other diseases","volume":"196","author":"Zhou","year":"2009","journal-title":"Acta. Physiol. (Oxf)"},{"issue":"25","key":"10.1016\/j.bioorg.2018.08.011_b0100","doi-asserted-by":"crossref","first-page":"20993","DOI":"10.18632\/oncotarget.3663","article-title":"Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bioorg.2018.08.011_b0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000317750","article-title":"Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2\/Bax ratio to induce apoptosis","volume":"56","author":"Zhou","year":"2010","journal-title":"Chemotherapy"},{"issue":"2","key":"10.1016\/j.bioorg.2018.08.011_b0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1573399054022785","article-title":"Molecular mechanisms of skeletal muscle insulin resistance in type 2 diabetes","volume":"1","author":"Bouzakri","year":"2005","journal-title":"Curr. Diabetes Rev."},{"issue":"7121","key":"10.1016\/j.bioorg.2018.08.011_b0115","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature05483","article-title":"Adipocytes as regulators of energy balance and glucose homeostasis","volume":"444","author":"Rosen","year":"2006","journal-title":"Nature"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818306849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818306849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T19:54:43Z","timestamp":1549742083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818306849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":23,"alternative-id":["S0045206818306849"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.08.011","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginkgolic acid as a dual-targeting inhibitor for protein tyrosine phosphatases relevant to insulin resistance","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}